Mirae Asset Global Investments Co., Ltd.

Filing Details

13F-HR • 2025-03-31
SEC
Report Date
2025-03-31
Filing Date
2025-04-24
Total Holdings
1,827
Total Value
23729973945
Accession Number
0000905148-25-001297
Form Type
13F-HR
CIK
0001569395
Manager Name
Mirae Asset Global Investments Co., Ltd.
Data Enrichment
87% identified
1,585 identified242 unidentified

Holdings

1,827 positions
Manager:
SEC
Search and click to pin securities to the top
Page 71 of 80
HUTCHMED (China) Ltd
HCM|44842L103
Shares:
1038(+0.4%)
Value:
$15.8M(+7.3%)
Summit Hotel Properties, Inc.
INN|866082100
Shares:
2928(-3.1%)
Value:
$15.8M(-22.9%)
Oruka Therapeutics, Inc.
ORKA|687604108
Shares:
1253(+7.5%)
Value:
$15.7M(-29.3%)
PRECIGEN, INC.
PGEN|74017N105
Shares:
9800(+0.4%)
Value:
$15.6M(+119.8%)
ZEEKR Intelligent Technology Holding Ltd
ZK|98923K103
Shares:
640(+5.4%)
Value:
$15.5M(-9.4%)
Verve Therapeutics, Inc.
VERV|92539P101
Shares:
2971(+5.3%)
Value:
$15.5M(-8.7%)
Mind Medicine (MindMed) Inc.
MNMD|60255C885
Shares:
2454(+0.4%)
Value:
$15.2M(-9.1%)
Theravance Biopharma, Inc.
TBPH|G8807B106
Shares:
1645(+0.4%)
Value:
$15.2M(-3.4%)
Phathom Pharmaceuticals, Inc.
PHAT|71722W107
Shares:
2288(+0.4%)
Value:
$15.1M(-19.0%)
Relay Therapeutics, Inc.
RLAY|75943R102
Shares:
5520(-1.0%)
Value:
$15.0M(-38.3%)
Global Medical REIT Inc.
GMRE|37954A204
Shares:
1714(-1.4%)
Value:
$15.0M(+13.2%)
78467V608
78467V608
Shares:
364(-7.6%)
Value:
$15.0M(-9.0%)
Keros Therapeutics, Inc.
KROS|492327101
Shares:
1360(+0.7%)
Value:
$14.7M(-33.8%)
Tourmaline Bio, Inc.
TRML|89157D105
Shares:
879(+2.9%)
Value:
$14.6M(-17.1%)
PHIBRO ANIMAL HEALTH CORP
PAHC|71742Q106
Shares:
681(+0.4%)
Value:
$14.6M(+2.4%)
Oric Pharmaceuticals, Inc.
ORIC|68622P109
Shares:
2377(+1.1%)
Value:
$14.6M(-24.8%)
UNIVERSAL HEALTH REALTY INCOME TRUST
UHT|91359E105
Shares:
355(-3.3%)
Value:
$14.5M(+7.9%)
Erasca, Inc.
ERAS|29479A108
Shares:
9460(+0.4%)
Value:
$14.4M(-39.9%)
488445206
488445206
Shares:
1786(+0.4%)
Value:
$14.0M(-6.1%)
80004C200
80004C200
Shares:
286
Value:
$14.0M